Omni Pharmaceuticals Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series E

  • Investors
  • 13

Omni Pharmaceuticals General Information

Description

Manufacturer of generic and branded pharmaceuticals designed to focus on chronic diseases like Chronic Obstructive Pulmonary Disease (COPD) and asthma. The company's generic and branded pharmaceuticals which include inhalation dry powder, nasal and HFA aerosol and sustained release capsules and tablets are featured in drug delivery systems that are difficult to develop, manufacture, and replicate for regulated markets and for the China market, enabling regulated markets of North America, Europe and China to contribute their expertise and solve selected public health challenges.

Contact Information

Website
www.omni-pharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 801, 802, Sino-US Trust Financial Building
  • No. 8 Zhapu Road, Hongkou District
  • Shanghai
  • China
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Vertical(s)
Manufacturing
Corporate Office
  • Unit 801, 802, Sino-US Trust Financial Building
  • No. 8 Zhapu Road, Hongkou District
  • Shanghai
  • China

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Omni Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series E) 20-Nov-2024 Completed Generating Revenue
4. Later Stage VC (Series D) 27-Dec-2021 Completed Generating Revenue
3. Later Stage VC (Series C) 19-Oct-2017 Completed Generating Revenue
2. Early Stage VC (Series B) 22-Sep-2015 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Mar-2013 Completed Startup
To view Omni Pharmaceuticals’s complete valuation and funding history, request access »

Omni Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of generic and branded pharmaceuticals designed to focus on chronic diseases like Chronic Obstructive Pulmo
Pharmaceuticals
Shanghai, China

Berkeley Heights, NJ
 

New Delhi, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Omni Pharmaceuticals Competitors (8)

One of Omni Pharmaceuticals’s 8 competitors is Cormedix, a Corporation company based in Berkeley Heights, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cormedix Corporation Berkeley Heights, NJ
Mankind Pharma Formerly PE-Backed New Delhi, India
GlaxoSmithKline Consumer Nigeria Corporation Lagos, Nigeria
Lupin Corporation Mumbai, India
Dr. Reddy's Laboratories Corporation Hyderabad, India
You’re viewing 5 of 8 competitors. Get the full list »

Omni Pharmaceuticals Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Taicang Assets Management Group Asset Manager Minority
Bank of China Group Investment PE/Buyout Minority
Origins Capital Venture Capital Minority
Shanghai Healthcare Capital PE/Buyout Minority
Shanghai Zhangjiang Science & Technology Venture Capital Corporate Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

Omni Pharmaceuticals FAQs

  • When was Omni Pharmaceuticals founded?

    Omni Pharmaceuticals was founded in 2011.

  • Where is Omni Pharmaceuticals headquartered?

    Omni Pharmaceuticals is headquartered in Shanghai, China.

  • What industry is Omni Pharmaceuticals in?

    Omni Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Omni Pharmaceuticals a private or public company?

    Omni Pharmaceuticals is a Private company.

  • What is Omni Pharmaceuticals’s current revenue?

    The current revenue for Omni Pharmaceuticals is .

  • How much funding has Omni Pharmaceuticals raised over time?

    Omni Pharmaceuticals has raised $39.3M.

  • Who are Omni Pharmaceuticals’s investors?

    Taicang Assets Management Group, Bank of China Group Investment, Origins Capital, Shanghai Healthcare Capital, and Shanghai Zhangjiang Science & Technology Venture Capital are 5 of 13 investors who have invested in Omni Pharmaceuticals.

  • Who are Omni Pharmaceuticals’s competitors?

    Cormedix, Mankind Pharma, GlaxoSmithKline Consumer Nigeria, Lupin, and Dr. Reddy's Laboratories are some of the 8 competitors of Omni Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »